Medical Devices: Page 2
-
AI devices with no clinical validation tied to more recalls, study finds
Public companies, which accounted for about half of AI-enabled devices on the market, had a higher rate of recalls and a lower rate of clinical evidence, according to a JAMA study.
By Elise Reuter • Sept. 2, 2025 -
Medtech VC funding on track to hit highest value since 2021: PitchBook
“Larger rounds increasingly favor top-tier companies and AI-native startups, leaving other startups fighting for a smaller pool of capital,” the firm said.
By Nick Paul Taylor • Sept. 2, 2025 -
Explore the Trendline➔
Permission granted by Boston ScientificTrendlineNew medical devices are reshaping the medtech industry
From pulsed field ablation devices to glucose sensors and surgical robotics, new medical technologies are transforming patient care and how people manage their health.
By MedTech Dive staff -
J&J removes some Abiomed heart pump controllers from market
Abiomed reported one death associated with a pump driver circuit assembly that does not meet current specifications. The recall affects 69 controllers, a J&J spokesperson said.
By Susan Kelly • Aug. 28, 2025 -
Inspire CFO Rick Buchholz to step down at end of 2025
RBC analysts said their views on the company are unchanged because the departing CFO will see the “Inspire V roll-out efforts through to completion.”
By Nick Paul Taylor • Aug. 28, 2025 -
Intuitive to lay off 331 employees in California
The robotic surgery company, which filed a WARN notice with the state in August, plans for the layoffs to be effective in late October.
By Ricky Zipp • Updated Aug. 28, 2025 -
Insulet promotes Eric Benjamin to chief operating officer
As new CEO Ashley McEvoy works to build the brand globally, the diabetes tech company also hired Manoj Raghunandanan as chief growth officer.
By Elise Reuter • Aug. 26, 2025 -
Terumo to buy OrganOx for $1.5B to enter transplant field
OrganOx could capture a greater share of the liver transplant market, where it competes with TransMedics Group, Needham analyst Mike Matson wrote.
By Susan Kelly • Aug. 25, 2025 -
Medtech firms shuffle execs in 2025
Top leaders at Intuitive, Boston Scientific, Dexcom and others changed roles this year. Read MedTech Dive’s roundup for all the details.
By Elise Reuter • Aug. 25, 2025 -
Sponsored by PAXXUS
Sustainable medical device packaging solutions: Mono-materials that perform
Mono-material packaging meets tough healthcare demands while improving recyclability.
Aug. 25, 2025 -
Boston Scientific recalls carotid stents over manufacturing defect
The FDA said the defect could injure blood vessels, damage the stent or release debris that could travel to the brain and cause a stroke.
By Nick Paul Taylor • Aug. 25, 2025 -
The robotic surgery market battle is heating up
After a busy summer of surgical robotics news, check out MedTech Dive’s roundup of coverage in the space.
By Susan Kelly • Aug. 22, 2025 -
MedTech Europe sounds alarm over impact of US-EU tariffs on patients
The trade group wants the U.S. to eliminate tariffs on medical technologies, warning that “patients cannot be collateral damage in trade tensions.”
By Nick Paul Taylor • Aug. 22, 2025 -
More than 1,100 devices have received the FDA’s breakthrough designation
The FDA updated its list of breakthrough devices as medtech groups lobby for faster Medicare coverage of products with the designation.
By Elise Reuter • Aug. 21, 2025 -
US, EU agree to terms of framework trade pact
The two trading partners documented provisions of a deal that would set a 15% tariff on many EU imports, including cars, auto parts, pharmaceuticals and semiconductors.
By Philip Neuffer • Aug. 21, 2025 -
AdvaMed urges Dr. Oz to speed Medicare coverage of breakthrough devices
The medtech trade group wants the CMS to take “bold action” to cut the lag between FDA authorization of devices and Medicare coverage.
By Nick Paul Taylor • Aug. 21, 2025 -
Q&A
How Aktiia built the first over-the-counter cuffless blood pressure monitor
Aktiia received FDA clearance in July for the first cuffless blood pressure monitor authorized to be sold over the counter.
By Elise Reuter • Aug. 20, 2025 -
NeuroOne gains FDA clearance for trigeminal nerve ablation
The minimally invasive system uses radiofrequency energy to target nerve tissue causing facial pain.
By Susan Kelly • Aug. 20, 2025 -
CMR Surgical hires Chris O’Hara to drive US robot expansion
O’Hara joins CMR’s executive team as commercial president and general manager for the U.S., following the FDA’s authorization last fall for its Versius system.
By Susan Kelly • Aug. 19, 2025 -
Medtronic recall of heart vent catheters tied to 3 serious injuries
The FDA said the request to quarantine the devices followed reports of the products “resisting shape retention when being bent.”
By Nick Paul Taylor • Aug. 19, 2025 -
Heart devices pace medtech’s summer funding flows
July and August have brought a steady beat of private financings for young medtech companies, with several deals supporting new technologies to treat heart conditions.
By Susan Kelly • Aug. 18, 2025 -
Philips will spend $150M to expand manufacturing for AI-enabled tech
The investment includes increasing manufacturing and research and development capabilities at its Reedsville, Pennsylvania, facility.
By Elise Reuter • Aug. 15, 2025 -
Trump says semiconductor tariffs to come next week
The president indicated that duties on chips would be “approximately 100%” earlier this month.
By Philip Neuffer • Aug. 15, 2025 -
Apple updates smart watches with blood oxygen feature after customs ruling
Apple said it was able to bring a redesigned blood oxygen feature to its devices after a recent U.S. customs ruling.
By Elise Reuter • Aug. 14, 2025 -
Reprieve Cardiovascular raises $61M; Conformal Medical nets $32M for LAAO
The fresh funding will support pivotal trials in progress and commercialization preparations at the two heart-focused companies.
By Susan Kelly • Aug. 14, 2025 -
Vicarious Surgical delays robot timeline
Days into the job, CEO Stephen From said the company no longer expects to begin a clinical trial for its robotic system by the end of the year.
By Susan Kelly • Aug. 13, 2025